Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引：0
|
作者：
Wei-Lin Liang
Bo Liang
机构：
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [41] Vericiguat - soluble guanylate cyclase stimulator, in therapy of heart failure
    Melenovsky, Vojtech
    COR ET VASA, 2022, 64 (03) : 316 - 319
  • [42] Soluble guanylate cyclase (sGC) activator Heart failure therapy
    Gras, J.
    DRUGS OF THE FUTURE, 2018, 43 (08) : 573 - 580
  • [43] Soluble guanylate cyclase: a potential therapeutic target for heart failure
    Gheorghiade, Mihai
    Marti, Catherine N.
    Sabbah, Hani N.
    Roessig, Lothar
    Greene, Stephen J.
    Boehm, Michael
    Burnett, John C.
    Campia, Umberto
    Cleland, John G. F.
    Collins, Sean P.
    Fonarow, Gregg C.
    Levy, Phillip D.
    Metra, Marco
    Pitt, Bertram
    Ponikowski, Piotr
    Sato, Naoki
    Voors, Adriaan A.
    Stasch, Johannes-Peter
    Butler, Javed
    HEART FAILURE REVIEWS, 2013, 18 (02) : 123 - 134
  • [44] Soluble guanylate cyclase: a potential therapeutic target for heart failure
    Mihai Gheorghiade
    Catherine N. Marti
    Hani N. Sabbah
    Lothar Roessig
    Stephen J. Greene
    Michael Böhm
    John C. Burnett
    Umberto Campia
    John G. F. Cleland
    Sean P. Collins
    Gregg C. Fonarow
    Phillip D. Levy
    Marco Metra
    Bertram Pitt
    Piotr Ponikowski
    Naoki Sato
    Adriaan A. Voors
    Johannes-Peter Stasch
    Javed Butler
    Heart Failure Reviews, 2013, 18 : 123 - 134
  • [45] Is there a role for soluble guanylate cyclase stimulators in acute pulmonary embolism?
    Appavu, Samuel K.
    CRITICAL CARE MEDICINE, 2011, 39 (12) : 2773 - 2774
  • [46] Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
    Cody Koress
    Kevin Swan
    Philip Kadowitz
    Current Hypertension Reports, 2016, 18
  • [47] Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
    Koress, Cody
    Swan, Kevin
    Kadowitz, Philip
    CURRENT HYPERTENSION REPORTS, 2016, 18 (05)
  • [48] Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease
    Kosmac, Kate
    Ismaeel, Ahmed
    Kim-Shapiro, Daniel B.
    McDermott, Mary M.
    CIRCULATION RESEARCH, 2023, 132 (01) : 49 - 51
  • [49] Activators of the nitric oxide sensor, soluble guanylate cyclase
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (11) : 1765 - 1770
  • [50] Soluble guanylate cyclase stimulators and their potential use: a patent review
    Sandner, Peter
    Vakalopoulos, Alexandros
    Hahn, Michael G.
    Stasch, Johannes-Peter
    Follmann, Markus
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (03) : 203 - 222
12345